Haris Ali

Trials

Studies that name Haris Ali as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 16:40 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT06128070 · Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

  City of Hope Medical Center · recruiting · Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome · principal investigator
• Ph2
  NCT04339101 · Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation

  City of Hope Medical Center · completed · Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome · principal investigator
• Ph1
  NCT02917096 · Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis

  City of Hope Medical Center · completed · Primary Myelofibrosis, Secondary Myelofibrosis · principal investigator
• Ph1
  NCT02528877 · Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis

  City of Hope Medical Center · withdrawn · Acute Myeloid Leukemia in Remission, Primary Myelofibrosis, Primary Myelofibrosis, Prefibrotic Stage · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 16:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Leadership, Planning and Evaluation
  P30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI JOHN D. CARPTEN · fiscal years 2004 to 2026
  Named on NCT06128070